4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-17-007337
Director bought 2,692,307 shares at $2.60 ($6,999,998)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. Director | 2017-10-13 | Purchase | +2,692,307 | $2.60 | $6,999,998 | 29,971,561 | D: show line 1 in the form |
| BROADWOOD PARTNERS, L.P. Director | 2017-10-13 | Purchase | +0 | 29,971,561 | I: show line 2 in the form | ||
| Open-market purchases · 2,692,307 sh · avg $2.60 · $6,999,998 | |||||||
Loading xslF345X03/p7683481.xml…